切换至 "中华医学电子期刊资源库"

中华胃肠内镜电子杂志 ›› 2021, Vol. 08 ›› Issue (04) : 171 -175. doi: 10.3877/cma.j.issn.2095-7157.2021.04.005

论著

经口内镜下贲门缩窄术和双倍剂量艾司奥美拉唑治疗难治性胃食管反流病的临床疗效对比
曹会霞1, 熊英2, 韩静3,(), 张金卓3, 杨义超3, 王亚玲4, 杨崇阳3   
  1. 1. 067000 承德,河北省承德医学院
    2. 071000 保定,河北省保定市第一中心医院消化内三科;071000 保定,河北省保定市第一中心医院内镜中心
    3. 071000 保定,河北省保定市第一中心医院消化内三科
    4. 071000 保定,河北省保定市第一中心医院耳鼻喉科
  • 收稿日期:2021-09-11 出版日期:2021-11-15
  • 通信作者: 韩静
  • 基金资助:
    河北省保定市科技计划项目(1951ZF067)

Comparison of peroral endoscopic cardial constriction and double-dose esomeprazole on clinical efficacy of refractory gastroesophageal reflux disease

Huixia Cao1, Ying Xiong2, Jing Han3,(), Jinzhuo Zhang3, Yichao Yang3, Yaling Wang4, Chongyang Yang3   

  1. 1. Chengde Medical University, Chengde 067000, China
    2. Department of Digestive, Baoding No.1 Central Hospital, Baoding 071000, China; Endoscopy Center, Baoding No.1 Central Hospital, Baoding 071000, China
    3. Department of Digestive, Baoding No.1 Central Hospital, Baoding 071000, China
    4. Department of Otolaryngology, Baoding No.1 Central Hospital, Baoding 071000, China
  • Received:2021-09-11 Published:2021-11-15
  • Corresponding author: Jing Han
引用本文:

曹会霞, 熊英, 韩静, 张金卓, 杨义超, 王亚玲, 杨崇阳. 经口内镜下贲门缩窄术和双倍剂量艾司奥美拉唑治疗难治性胃食管反流病的临床疗效对比[J]. 中华胃肠内镜电子杂志, 2021, 08(04): 171-175.

Huixia Cao, Ying Xiong, Jing Han, Jinzhuo Zhang, Yichao Yang, Yaling Wang, Chongyang Yang. Comparison of peroral endoscopic cardial constriction and double-dose esomeprazole on clinical efficacy of refractory gastroesophageal reflux disease[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2021, 08(04): 171-175.

目的

比较经口内镜下贲门缩窄术(PECC)与双倍剂量艾司奥美拉唑治疗难治性胃食管反流病(rGERD)的临床疗效。

方法

选取保定市第一中心医院2019年1月至2020年5月的rGERD患者64例进行前瞻性随机对照研究。按照随机对照原则将符合纳入标准患者分为PECC组及艾司奥美拉唑组,每组各32例。前者接受PECC治疗,后者口服艾司奥美拉唑及枸橼酸莫沙比利,对比两组患者治疗后3、6个月反流症状、生活质量评分及满意度。

结果

PECC组患者治疗后3个月及6个月反流性疾病问卷(RDQ)、反流症状指数评分量表(RSI)、胃食管反流病健康相关生活质量评分(GERD-HRQL),评分均明显低于艾司奥美拉唑组(P<0.01)。治疗后6个月PECC组满意度为87.5%(28/32)、艾司奥美拉唑组满意度为40.63%(13/32)。两组患者满意度有统计学差异(P<0.05),且PECC组患者无明显严重并发症。

结论

短期疗效来说PECC比两倍剂量艾司奥美拉唑在改善rGERD患者反流症状及提高生活质量方面更有优势,可缓解rGERD咽喉反流症状,显著改善rGERD反酸、烧心等食管反流症状,明显提高生活质量,可以作为rGERD治疗选择方案。

Objective

To compare the clinical efficacy of peroral endoscopic cardial constriction (PECC) and double-dose esomeprazole on the treatment of refractory gastroesophageal reflux disease (rGERD).

Methods

A prospective randomized controlled study was conducted on the data of 64 patients with rGERD at Baoding No.1 Central Hospital from January 2019 to May 2020. According to the principle of randomized control trial, patients were divided into PECC group and esomeprazole group, with 32 cases in each group.The former under went PECC and the latter taken oral esomeprazole and mosapride citrate. The reflux symptoms, quality of life scores and satisfaction between the two groups were compared after 3 and 6 months.

Results

After 3 and 6 months follow-up reflux disease questionnaire (RDQ), reflux symptom index (RSI), health related quality of life scale gastroesophageal reflux disease (GERD-HRQL) scores in the PECC group were significantly lower than those in the esomeprazole group (P<0.01). After 6 months follow-up, the satisfaction rate of PECC group and esomeprazole group was 87.5% (28/32) and 40.63% (13/32), respectively.There was significant difference in satisfaction between the two groups (P<0.05), and no obvious serious complications in the PECC group.

Conclusion

In terms of short-term efficacy, PECC is more advantageous than double-dose esomeprazole in improving reflux symptoms and enhancing quality of life in patients with rGERD. It can alleviate the symptoms of rGERD throat reflux, and significantly reduce rGERD acid reflux、heartburn and other esophageal reflux symptoms. It can distinctly improve the quality of life and can be used as a treatment option for rGERD.

表1 两组患者治疗前基线资料比较
图1 经口内镜下贲门缩窄术手术操作步骤注:A:内镜下可见食管下端充血糜烂黏膜融合成片;B:反转镜身可见2 cm左右食管裂孔疝,贲门口松弛;C:充分吸引黏膜及部分肌层,套扎环套扎
表2 两组患者治疗3、6个月后疗效对比(±s)
[1]
Eusebi LH, Ratnakumaran R, Yuan Y,et al. Global prevalence of, and risk factors for,gastro-oesophageal reflux symptoms:a meta-analysis[J]. Gut201867(3):430-440.
[2]
Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux disease[J]. BMJ2020371:m3786.
[3]
Delshad SD, Almario CV, Chey WD,et al.Prevalence of gastroesophageal reflux disease and proton pump inhibitor-refractory symptoms[J]. Gastroenterology2020158(5):1250-1261.
[4]
中华医学会消化病学分会.2020年中国胃食管反流病专家共识[J].中华消化杂志202040(10):649-663.
[5]
Li ZT, Ji F, Han XW, et al. Endoscopic cardial constriction with band ligation in the treatment of refractory gastroesophageal reflux disease: a preliminary feasibility study[J]. Surg Endosc202135(7):4035-4041.
[6]
胡海清,柴宁莉,令狐恩强,等. 经口内镜下贲门缩窄术治疗胃食管反流病的临床研究[J/CD].中华胃肠内镜电子杂志20163(2):65-67.
[7]
令狐恩强,王宇菲,王潇潇.经口内镜下贲门缩窄术治疗胃食管反流病的报道一例[J/CD].中华腔镜外科杂志(电子版)20136(6):468-469.
[8]
唐小波,王亚雷,许建明.胃食管反流病问卷在胃食管反流病诊断中的价值[J].安徽医科大学学报201146(3):275-278.
[9]
Akbulut S, Aydinli FE, Kuşçu O,et al. Reliability and Validity of the Turkish Reflux Symptom Index[J]. J Voice202034(6):965. e23-965. e28.
[10]
Ionova TI, Nikitina TP, Mayevskaya EA,et al. Development of the Russian version of quality of life questionnaire in patients with GERD-GERD-HRQL[J]. Ter Arkh202092(8):12-17.
[11]
El-Serag H, Becher A, Jones R. Systematic review:persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies[J]. Aliment Pharmacol Ther201032(6):720-737.
[12]
Hillman L, Yadlapati R, Thuluvath AJ,et al. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease[J]. Dis Esophagus201730(9):1-15.
[13]
Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of gastroesophageal reflux disease:Where rome,Lyon,and Montreal Meet[J]. Clin Gastroenterol Hepatol202018(4):767-776.
[14]
Gyawali CP, Kahrilas PJ, Savarino E,et al. Modern diagnosis of GERD: the Lyon Consensus[J]. Gut201867(7):1351-1362.
[15]
Lee JY, Kim SK, Cho KB, et al. A Double-blind, Randomized, Multicenter Clinical Trial Investigating the Efficacy and Safety of Esomeprazole Single Therapy Versus Mosapride and Esomeprazole Combined Therapy in Patients with Esophageal Reflux Disease[J]. J Neurogastroenterol Motil201723(2):218-228.
[16]
Bai Y, Du Y, Zou D,et al. Gastroesophageal Reflux Disease Questionnaire(GerdQ)in real-world practice:a national multicenter survey on 8065 patients[J]. J Gastroenterol Hepatol201328(4): 626-631.
[1] 麦苏德·马合木提, 丹尼尔·多里坤, 张海平, 张力为, 伊地力斯·阿吾提. 胸腔镜辅助微创手术(改良型Nuss术)矫正治疗小儿漏斗胸的临床疗效[J]. 中华妇幼临床医学杂志(电子版), 2022, 18(02): 228-233.
[2] 黄海, 蒙建源, 陈福才, 曹玉华, 朱刚健. 免充气腋窝入路腔镜技术与传统方式用于甲状腺次全切除术的对照研究[J]. 中华普外科手术学杂志(电子版), 2022, 16(02): 233-236.
[3] 陈丽茹, 吴小凤, 唐守艳, 吴婵, 邓含, 冯钰. 废液引流俯卧位包的设计及其在经皮肾镜术中的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 219-222.
[4] 张芝, 孙海云. 舒适护理对老年腹股沟疝患者腹腔镜手术后睡眠质量及满意度的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 488-490.
[5] 金淑溶, 李坤, 刘晨鹏, 潘振宇. 精细化检查流程在盆底疝动态磁共振成像中的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(02): 223-226.
[6] 郭娜, 徐立丽, 肖芳, 韩晓静. 综合护理在小儿腹股沟疝围手术期护理中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2022, 16(03): 358-361.
[7] 徐静媛, 陈辉, 谢波, 刘玲, 杨毅. 提高重症医学教学查房满意度的教学模式[J]. 中华重症医学电子杂志, 2022, 08(03): 248-252.
[8] 姜里蛟, 张峰, 周玉萍. 多学科诊疗模式救治老年急性非静脉曲张性上消化道大出血患者的临床观察[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 520-524.
[9] 阳秀春, 刘觉仕, 祝芝兰, 徐源, 唐慧玲. 住院患者检查清单在介入科病房的应用探讨[J]. 中华介入放射学电子杂志, 2022, 10(01): 102-105.
[10] 李新华, 罗依, 袁颖, 黄颖, 徐美华, 吴静. 以学生为中心的线上线下混合式教学改革在交流技能学中的应用[J]. 中华诊断学电子杂志, 2023, 11(04): 217-221.
[11] 李鹏, 刘国祥, 李汝红. 经口内镜下贲门缩窄术治疗胃食管反流病的研究进展[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 96-99.
[12] 范勇, 张利昉, 杨美琳. 改良经口内镜下贲门缩窄术治疗胃食管反流病效果分析[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 65-68.
[13] 马建惠, 文明, 谢芳, 韩琦. 人性化护理在心房颤动合并胃食管反流患者射频消融术中的应用及满意度分析[J]. 中华胃食管反流病电子杂志, 2023, 10(01): 46-49.
[14] 王雯, 王志, 胡传国. 连朴饮加减与艾司奥美拉唑及莫沙必利联合治疗对反流性食管炎患者神经递质及血清CGRP、IL-1β、IL-17的影响[J]. 中华胃食管反流病电子杂志, 2023, 10(01): 6-10.
[15] 魏盈盈, 潘鑫, 李岑, 曹俊辉, 顾慧, 王忻, 杨声远. 基于胸痛中心急救流程在急性心肌梗死患者救治中的应用[J]. 中华卫生应急电子杂志, 2022, 08(02): 86-88.
阅读次数
全文


摘要